Kryger Capital’s Verona Pharma VRNA Stock Holding History

Kryger Capital’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-962,341	Closed	-$103M	–	64
2025 Q3	$103M	Buy	+962,341	New	+$100M	11.86%	1

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Kryger Capital's VRNA Position: Q4 2025 in Review

Kryger Capital sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 962,341 shares — an estimated $103M sold.

Kryger Capital first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $103M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Kryger Capital reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Kryger Capital sold 962,341 Verona Pharma shares in Q4 2025, an estimated $103M.
Kryger Capital first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Kryger Capital's Verona Pharma position peaked at $103M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Kryger Capital's 13F filing for Q4 2025, filed 17 Feb 2026.